Gland Pharma Ltd Nine Monthly Results

Gross Sales

4,191.6

4,127.27

2,839.59

3,297.69

2,575.13

Excise Duty

0

0

0

0

0

Net Sales

4,191.6

4,127.27

2,839.59

3,297.69

2,575.13

Other Operating Income

0

0

0

0

0

Other Income

169.58

128.09

201.52

158.7

87.56

Total Income

4,361.17

4,255.36

3,041.11

3,456.4

2,662.69

Total Expenditure

3,270.19

3,152.85

1,983.25

2,135.9

1,600.58

PBIDT

1,090.99

1,102.51

1,057.87

1,320.5

1,062.12

Interest

34.55

16.24

5.24

3.21

2.39

PBDT

1,056.44

1,086.27

1,052.63

1,317.29

1,059.73

Depreciation

282.11

251.96

109.19

79.22

73.86

Minority Interest Before NP

0

0

0

0

0

Tax

268.24

245.58

233.37

307.62

250.51

Deferred Tax

-5.9

8.69

7.7

4.69

-1.19

Reported Profit After Tax

511.99

580.04

702.36

925.76

736.55

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

511.99

580.04

702.36

925.76

736.55

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

511.99

580.04

702.36

925.76

736.55

EPS (Unit Curr.)

31.08

35.22

42.67

56.41

47.12

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.48

16.47

16.47

16.43

16.33

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.02

26.71

37.25

40.04

41.24

PBDTM(%)

25.2

26.31

37.06

39.94

41.15

PATM(%)

12.21

14.05

24.73

28.07

28.6